Johnson, B J <br/><br/>
rhuIL-2 adjunctive therapy in multidrug resistant tuberculosis: a comparison of two treatment regimens and placebo.  [electronic resource] 

 -  Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease  1997 
 - 195-203 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0962-8479 
<br/><br/><label>Standard No.: </label>10.1016/s0962-8479(97)90026-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antitubercular Agents--therapeutic use<br/>CD56 Antigen--blood<br/>Chemotherapy, Adjuvant<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Immunophenotyping<br/>Interleukin-2--administration & dosage<br/>Lung--diagnostic imaging<br/>Male<br/>Middle Aged<br/>Radiography<br/>Receptors, Interleukin-2--blood<br/>Recombinant Proteins--administration & dosage<br/>Sputum--microbiology<br/>Tuberculosis, Multidrug-Resistant--diagnostic imaging